00482nas a2200169   4500000000100000008004100001100001400042700002000056700001600076700001400092700001500106700001400121245014500135300001000280490000800290022001400298       2018                            d1 aA. Douros1 aS. Dell'Aniello1 aO. H. Y. Yu1 aK. Filion1 aL. Azoulay1 aS. Suissa00aSulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study  ak26930 v362  a0959-8138